BIOMAT Database Logo BIOMAT Database Logo

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. 1986

D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde

In postmortem studies of patients with schizophrenia, D2 dopamine receptors in the basal ganglia have been observed to be more numerous than in patients with no history of neurological or psychiatric disease. Because most patients with schizophrenia are treated with neuroleptic drugs that block D2 dopamine receptors in the caudate nucleus, it has been suggested that this increase in the number of receptors is a result of adaptation to these drugs rather than a biochemical abnormality intrinsic to schizophrenia. With positron emission tomography (PET), the D2 dopamine receptor density in the caudate nucleus of living human beings was measured in normal volunteers and in two groups of patients with schizophrenia--one group that had never been treated with neuroleptics and another group that had been treated with these drugs. D2 dopamine receptor densities in the caudate nucleus were higher in both groups of patients than in the normal volunteers. Thus, schizophrenia itself is associated with an increase in brain D2 dopamine receptor density.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone
D014055 Tomography, Emission-Computed Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image. CAT Scan, Radionuclide,CT Scan, Radionuclide,Computerized Emission Tomography,Radionuclide Tomography, Computed,Scintigraphy, Computed Tomographic,Tomography, Radionuclide-Computed,Computed Tomographic Scintigraphy,Emission-Computed Tomography,Radionuclide Computer-Assisted Tomography,Radionuclide Computerized Tomography,Radionuclide-Computed Tomography,Radionuclide-Emission Computed Tomography,Tomography, Computerized Emission,CAT Scans, Radionuclide,CT Scans, Radionuclide,Computed Radionuclide Tomography,Computed Tomography, Radionuclide-Emission,Computer-Assisted Tomographies, Radionuclide,Computer-Assisted Tomography, Radionuclide,Computerized Tomography, Radionuclide,Emission Computed Tomography,Emission Tomography, Computerized,Radionuclide CAT Scan,Radionuclide CAT Scans,Radionuclide CT Scan,Radionuclide CT Scans,Radionuclide Computed Tomography,Radionuclide Computer Assisted Tomography,Radionuclide Computer-Assisted Tomographies,Radionuclide Emission Computed Tomography,Scan, Radionuclide CAT,Scan, Radionuclide CT,Scans, Radionuclide CAT,Scans, Radionuclide CT,Tomographic Scintigraphy, Computed,Tomographies, Radionuclide Computer-Assisted,Tomography, Computed Radionuclide,Tomography, Emission Computed,Tomography, Radionuclide Computed,Tomography, Radionuclide Computer-Assisted,Tomography, Radionuclide Computerized,Tomography, Radionuclide-Emission Computed
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Elevated D2 dopamine receptors in drug-naïve schizophrenics.
February 1988, Science (New York, N.Y.),
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
August 1995, Psychiatry research,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
March 1990, Archives of general psychiatry,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
February 1994, Archives of general psychiatry,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
September 1995, Neurology,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Imaging of dopamine D1 and D2 receptors by a high resolution positron emission tomography.
January 1991, Advances in experimental medicine and biology,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.
May 2013, NeuroImage,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
[Positron emission tomography studies of dopamine D1 receptors].
July 1991, Nihon rinsho. Japanese journal of clinical medicine,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
October 2010, Biological psychiatry,
D F Wong, and H N Wagner, and L E Tune, and R F Dannals, and G D Pearlson, and J M Links, and C A Tamminga, and E P Broussolle, and H T Ravert, and A A Wilson, and J K Toung, and J Malat, and J A Williams, and L A O'Tuama, and S H Snyder, and M J Kuhar, and A Gjedde
Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
December 1993, Psychiatry research,
Copied contents to your clipboard!